Sinohealth Technology Holdings Limited (HKG:2361)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.08
+0.01 (0.20%)
At close: Apr 15, 2026

HKG:2361 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
419.09403.73396.19356.67324.17
Revenue Growth (YoY)
3.81%1.90%11.08%10.03%60.42%
Cost of Revenue
170.04170.53172.72197.56131.53
Gross Profit
249.05233.2223.47159.11192.64
Selling, General & Admin
75.7878.5867.0577.7768.95
Research & Development
73.5764.7761.0960.4153.71
Other Operating Expenses
----0.02
Operating Expenses
157.43152.69145.75140.86125.19
Operating Income
91.6280.5177.7218.2567.45
Interest Expense
-0.44-0.62-0.64-0.41-0.53
Interest & Investment Income
23.526.8827.1715.116.97
Earnings From Equity Investments
-0.47----0.42
Currency Exchange Gain (Loss)
-4.862.299.530.04
Other Non Operating Income (Expenses)
-8.758.464.1911.4416.1
EBT Excluding Unusual Items
105.47120.09110.7353.9289.61
Gain (Loss) on Sale of Investments
---0.044.82
Gain (Loss) on Sale of Assets
0.06--0.52-
Other Unusual Items
-0.060.01-1.11
Pretax Income
105.53120.15110.7454.4795.53
Income Tax Expense
11.038.339.80.2623.55
Earnings From Continuing Operations
94.5111.82100.9454.2171.98
Minority Interest in Earnings
-1.06-1.171.091.556.84
Net Income
93.44110.65102.0355.7678.81
Net Income to Common
93.44110.65102.0355.7678.81
Net Income Growth
-15.55%8.45%82.99%-29.25%16.03%
Shares Outstanding (Basic)
452410426411373
Shares Outstanding (Diluted)
452410426411373
Shares Change (YoY)
10.13%-3.74%3.76%10.06%-
EPS (Basic)
0.210.270.240.140.21
EPS (Diluted)
0.210.270.240.140.21
EPS Growth
-23.32%12.65%76.35%-35.72%-
Free Cash Flow
-89.4375.9429.7858.14
Free Cash Flow Per Share
-0.220.180.070.16
Dividend Per Share
0.0640.1130.0660.035-
Dividend Growth
-43.26%71.35%86.93%--
Gross Margin
59.43%57.76%56.41%44.61%59.43%
Operating Margin
21.86%19.94%19.62%5.12%20.81%
Profit Margin
22.30%27.41%25.75%15.63%24.31%
Free Cash Flow Margin
-22.15%19.17%8.35%17.94%
EBITDA
94.2683.1580.1520.9169.53
EBITDA Margin
22.49%20.59%20.23%5.86%21.45%
D&A For EBITDA
2.642.642.432.662.08
EBIT
91.6280.5177.7218.2567.45
EBIT Margin
21.86%19.94%19.62%5.12%20.81%
Effective Tax Rate
10.45%6.93%8.85%0.48%24.65%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.